Protein Tyrosine Phosphatase Receptors N and N2 Control Pituitary Melanotroph Development and POMC Expression
Endocrinology · 2024
DOI: 10.1210/endocr/bqae076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Stephanie Constantin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section on Cellular Signaling, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Pro-Opiomelanocortin, Mice, Knockout, Pituitary Gland, Melanotrophs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH HHS.
Abstract (Originalsprache)
The neuroendocrine marker genes Ptprn and Ptprn2 encode protein tyrosine phosphatase receptors N and N2, 2 members of protein tyrosine phosphatase receptors void of enzymatic activity, and whose function and mechanism of action have not been elucidated. To explore the role(s) of Ptprn and Ptprn2 on the hypothalamic-pituitary-adrenal axis, we used mice in which both genes were knocked out (DKO). The focus in this study was on corticotrophs and melanotrophs from the anterior and intermediate lobes of the pituitary gland, respectively. In both sexes, DKO caused an increase in the expression of the corticotroph/melanotroph genes Pomc and Tbx19 and the melanotroph-specific gene Pax7. We also found in vivo and in vitro increased synthesis and release of beta-endorphin, alpha-melanocyte-stimulating hormone, and ACTH in DKO mice, which was associated with increased serum corticosterone levels and adrenal mass. DKO also increased the expression of other melanotroph-specific genes, but not corticotroph-specific genes. The dopaminergic pathway in the hypothalamus and dopaminergic receptors in melanotrophs were not affected in DKO mice. However, hyperplasia of the intermediate lobe was observed in DKO females and males, accompanied by increased proopiomelanocortin immunoreactivity per cell. These results indicate that protein tyrosine phosphatase receptor type N contributes to hypothalamic-pituitary-adrenal function by being involved in processes governing postnatal melanotroph development and Pomc expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section on Cellular Signaling, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, USA.
- National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Stephanie Constantin, Kosara Smiljanic, Stanko S Stojilkovic
Förderung
- Intramural NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIH HHS
- National Institutes of Health
Zitieren
APA
Constantin, S., Sokanovic, S. J., Mochimaru, Y., Dams, A. L., Smiljanic, K., Prévide, R. M., Nessa, N., Carmona, G. N., & Stojilkovic, S. S. (2024). Protein Tyrosine Phosphatase Receptors N and N2 Control Pituitary Melanotroph Development and POMC Expression. Endocrinology. https://doi.org/10.1210/endocr/bqae076
Vancouver
Constantin S, Sokanovic SJ, Mochimaru Y, Dams AL, Smiljanic K, Prévide RM, et al. Protein Tyrosine Phosphatase Receptors N and N2 Control Pituitary Melanotroph Development and POMC Expression. Endocrinology. 2024. doi:10.1210/endocr/bqae076
BibTeX
@article{Constantin2024,
author = {Constantin, Stephanie and Sokanovic, Srdjan J and Mochimaru, Yuta and Dams, Aloa Lamarca and Smiljanic, Kosara and Prévide, Rafael M and Nessa, Naseratun and Carmona, Gilberto N and Stojilkovic, Stanko S},
title = {Protein Tyrosine Phosphatase Receptors N and N2 Control Pituitary Melanotroph Development and POMC Expression},
journal = {Endocrinology},
year = {2024},
doi = {10.1210/endocr/bqae076}
}
EUVIMED